Solvay cuts 2026 guidance as Solvay stock trades at EUR 23.42

Published on 10/27/2026 at 11:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 EBITDA reached EUR 173 million on October 19, 2026, below the new outlook. Solvay stock costs EUR 23.42 on October 27, 2026, while guidance is EUR 720-740 million.

Business updates and valuation

Philippe Kehren joined Cefic's Board and Executive Committee on October 22, 2026.
Solvay guides for underlying EBITDA of EUR 720 million to EUR 740 million in fiscal year 2026.
Solvay stock trades at EUR 23.42 at 10:48 a.m. CET at Lang & Schwarz on October 27, 2026.

Solvay, BE0003470755, Illustration mit AI erstellt.

Solvay (ISIN BE0003470755) was trading at EUR 23.42 at Lang & Schwarz on October 27, 2026, at 10:48 a.m. CET. The company had cut its 2026 financial outlook on October 19, while its chief executive Philippe Kehren took a new industry role on October 22.

According to Solvay, Kehren joined the Board and Executive Committee of Cefic, the European Chemical Industry Council, and became chair of its Advocacy Forum. The appointment puts Solvay's CEO into a wider debate on competitiveness, energy costs and decarbonization in Europe's chemical industry.

Three dates shape the picture

On October 12, 2026, Solvay introduced Solsys Care Max, which showed cleaning performance in tests at temperatures as low as 4 degrees Celsius and in wash cycles as short as 15 minutes. On October 19, 2026, the company reported preliminary third-quarter underlying net sales of EUR 1.03 billion, underlying EBITDA of EUR 173 million and free cash flow to shareholders of EUR 54 million through continuing operations, according to Solvay. On October 22, 2026, Kehren accepted the Cefic positions; the company has more than 8,400 employees, the same release said.

What does the revised outlook mean?

The revised 2026 underlying EBITDA guidance is EUR 720 million to EUR 740 million, while free cash flow from continuing operations is expected at EUR 120 million to EUR 150 million. MarketScreener reports that the previous EBITDA range was EUR 770 million to EUR 850 million and that the earlier free cash flow view was at least EUR 200 million. The updated range therefore lowers both ends of the EBITDA outlook.

The company attributed the pressure to the Middle East conflict and the shutdown of the peroxide plant at the Sadara complex in Jubail, Saudi Arabia. Solvay said the conflict reduced underlying EBITDA by EUR 25 million in the third quarter, including EUR 15 million linked to the plant shutdown. The final third-quarter results are scheduled for November 4, 2026, according to Solvay.

Cash generation sets the next test

The preliminary numbers make cash generation the key issue for the next report. Solvay's EUR 54 million third-quarter free cash flow sits alongside a full-year target of EUR 120 million to EUR 150 million, leaving the November figures important for assessing the effect of the Saudi Arabian disruption and transformation expenses.

Solvay was trading at EUR 23.42 at Lang & Schwarz on October 27, 2026, at 10:48 a.m. CET.